Chemico-Biological Interactions · 2023 · 27 citations · 31 references
MedicineNephrologyPharmacologyCell SignalingMolecular PharmacologySignal TransductionDiabetes Mellitus BiochemistryDiabetic Kidney DiseaseDiabetic NephropathyLipid MetabolismRenal DiseaseRenal PharmacologyAnimal Model EvaluationImmunofluorescence StainingLipid AccumulationLipid Metabolism EffectsLipid Metabolism PathwaysNf-κb SignalingPharmacological Network AnalysisWestern Blotting
Morroniside (MOR), a cyclic enol ether terpene glycoside isolated from Cornus officinalis, has been shown to inhibit lipid accumulation, although the mechanism of action is uncertain. The aim of this study was to investigate the potential pathways by which MOR affects renal lipid deposition in diabetic nephropathy (DN). In vitro and in vivo experiments were performed using the PA-induced HK-2 cell model and a KKAy animal model, respectively. Network pharmacological analysis was used to identify potential MOR signaling pathways for DN therapy, with results verified via Western blotting and immunofluorescence experiments. The effect of MOR on lipid metabolism was investigated using BODIPY 493/503 staining. Our results indicate that MOR significantly reduces lipid accumulation both in vitro and in vivo. According to network pharmacology studies, the NF-κB/TNF-α/SREBP1c signaling pathway may be the mechanism of action of MOR in DN. MOR was found to inhibit this pathway by reducing the phosphorylation of NF-κB p65 and the expression of TNF-α and SREBP1c, similar to the effects of Bay11-7082. Additionally, MOR significantly inhibited the expression of lipid factors such as ACC, FAS, and SCD1. In conclusion, MOR can regulate the disruption of lipid metabolism in DN and reduce renal lipid deposition via suppression of the NF-κB/TNF-α/SREBP1c signaling pathway.
31
Changes in Diabetes-Related Complications in the United States, 1990–2010
Edward W. Gregg, Yanfeng Li, Jing Wang et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text
Medicine, Oncology, Pharmacotherapy +15
LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE
J F Moorhead, M. El-Nahas, Man K. Chan et al. · The Lancet · 1982 · 1.1K citations
Medicine, Nephrology, Pathology +10
Tao Jiang, Zhuowei Wang, Gregory Proctor et al. · Journal of Biological Chemistry · 2005 · 388 citations · Full text